Drug Trial Radar · NCT07286331
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Jun 4, 2026
Primary completion
Feb 29, 2028
Study completion May 30, 2029
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- Collaborators
- ENGOT, GOG, APGOT
- First posted
- Dec 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study specifically aims to evaluate how well mocertatug rezetecan (Mo-Rez) works in treating Endometrial Cancer (EC) compared to standard of care. The study also assesses whether Mo-Rez is safe and tolerated well by participants in comparison to standard of care and will help provide a better understanding of the main side effects of the drugs.
Conditions
- Neoplasms, Endometrial
Interventions
Mocertatug rezetecanDrug
Mocertatug rezetecan will be administered
PaclitaxelDrug
Paclitaxel will be administered
DoxorubicinDrug
Doxorubicin will be administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rate (ORR) by BICRTime frame: Up to approximately 97 weeks
- Progression Free Survival (PFS) by BICRTime frame: Up to approximately 97 weeks
Locations
56 sites in 10 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Birmingham, Alabama · Recruiting
GSK Investigational Site
Omaha, Nebraska · Recruiting
GSK Investigational Site
Sugar Land, Texas · Recruiting
GSK Investigational Site
Charlottesville, Virginia · Recruiting
GSK Investigational Site
Buenos Aires, Argentina · Recruiting
GSK Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina · Recruiting
GSK Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina · Recruiting
GSK Investigational Site
Córdoba, Argentina · Recruiting
GSK Investigational Site
Rosario, Argentina · Recruiting
GSK Investigational Site
Florida, Buenos Aires, Argentina · Recruiting
GSK Investigational Site
Mendoza, MD, Argentina · Recruiting
GSK Investigational Site
Dubbo, New South Wales, Australia · Recruiting
GSK Investigational Site
Auchenflower, Queensland, Australia · Recruiting
GSK Investigational Site
Herston, Queensland, Australia · Recruiting
GSK Investigational Site
CuritibaPR, Brazil · Recruiting
GSK Investigational Site
Porto Alegre, Brazil · Recruiting
GSK Investigational Site
São Paulo, Brazil · Recruiting
GSK Investigational Site
São Paulo, Brazil · Recruiting
GSK Investigational Site
Vitória, Brazil · Recruiting
GSK Investigational Site
São Luís, Maranhão, Brazil · Recruiting
GSK Investigational Site
Toronto, Ontario, Canada · Recruiting
GSK Investigational Site
Montreal, Quebec, Canada · Recruiting
GSK Investigational Site
Montreal, Quebec, Canada · Recruiting
GSK Investigational Site
Haifa, Israel · Recruiting
GSK Investigational Site
Haifa, Israel · Recruiting
GSK Investigational Site
Kfar Saba, Israel · Recruiting
GSK Investigational Site
Aichi, Japan · Recruiting
GSK Investigational Site
Fukuoka, Japan · Recruiting
GSK Investigational Site
Hokkaido, Japan · Recruiting
GSK Investigational Site
Hyōgo, Japan · Recruiting
GSK Investigational Site
Kanagawa, Japan · Recruiting
GSK Investigational Site
Kanagawa, Japan · Recruiting
GSK Investigational Site
Kyoto, Japan · Recruiting
GSK Investigational Site
Mie, Japan · Recruiting
GSK Investigational Site
Numakunai, Japan · Recruiting
GSK Investigational Site
Okayama, Japan · Recruiting
GSK Investigational Site
Okinawa, Japan · Recruiting
GSK Investigational Site
Osaka, Japan · Recruiting
GSK Investigational Site
Saitama, Japan · Recruiting
GSK Investigational Site
Shizuoka, Japan · Recruiting
Showing 40 of 56 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.